COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

January 16, 2022

Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy.

Clinical Reviews in Allergy & Immunology
Zhangkai J ChengBaoqing Sun
January 16, 2022

Convalescent plasma for COVID-19. TSUNAMI is not the final word.

European Journal of Internal Medicine
Massimo FranchiniCesare Perotti
January 15, 2022
Open Access

Potential therapeutic options for COVID-19: an update on current evidence.

European Journal of Medical Research
Zahra NiknamYousef Rasmi
January 15, 2022

Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report.

Acta Medica Indonesiana
Mira YuliantiI Putu Eka Krisnha Wijaya
January 14, 2022
Open Access

High-cited favorable studies for COVID-19 treatments ineffective in large trials

MedRxiv : the Preprint Server for Health Sciences
John P.A. Ioannidis
January 14, 2022

COVID-19 and the impact on blood availability and transfusion practices in low- and middle-income countries.

Linda S BarnesQuentin G Eichbaum
January 14, 2022
Open Access

Coagulation profile of human COVID-19 convalescent plasma.

Scientific Reports
Allan M KlompasJonathon W Senefeld
January 13, 2022
Open Access

Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron.

BioRxiv : the Preprint Server for Biology
I-Ting TengPeter D Kwong
January 13, 2022

Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals?

Clinical and Experimental Immunology
David BakerRuth Dobson
January 12, 2022
Open Access

Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review.

International Journal of Molecular Sciences
Daniele Franchini FocosiA. Casadevall
January 12, 2022
Open Access

Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors.

International Journal of Environmental Research and Public Health
Jasmina GrujićPavle Banović
January 12, 2022

Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19.

Nature Medicine
M. J. JoynerA. Casadevall
January 10, 2022

Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Arun SankaradossEaswaran Sreekumar
January 11, 2022

Effect of convalescent plasma as complementary treatment in patients with moderate COVID-19 infection.

Transfusion Medicine
Manuel E BaldeónMarco Fornasini

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2022 Meta ULC. All rights reserved